Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1369 studies found for:    MACULAR DEGENERATION
Show Display Options
Rank Status Study
1 Completed Antioxidant Systems and Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention:
2 Completed VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
Condition: Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Other: No treatment
3 Completed Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
Condition: Advanced Age-related Macular Degeneration
Intervention: Biological: LFG316
4 Withdrawn Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: Telescope prosthesis;   Device: WA-NG Telescope Prothesis
5 Active, not recruiting Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)
Condition: Age-related Macular Degeneration
Interventions: Drug: Omega-3 fatty acids (fish oil);   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin D3 placebo;   Dietary Supplement: Fish oil placebo
6 Active, not recruiting Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention:
7 Not yet recruiting Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration
Condition: Macular Degeneration
Intervention: Device: Ocusweep system
8 Completed Complications of Age-Related Macular Degeneration Prevention Trial
Condition: Macular Degeneration
Intervention: Procedure: Low-Intensity Laser Treatment
9 Completed Size Progression of Macular Degeneration After Cataract Surgery
Condition: Age-Related Macular Degeneration
Intervention: Procedure: Cataract Surgery
10 No longer available Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
Condition: Macular Degeneration
Intervention: Drug: Anecortave Acetate
11 Completed
Has Results
Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice
Condition: Age-related Macular Degeneration
Intervention: Other: no intervention
12 Unknown  A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Condition: Macular Degeneration
Intervention: Drug: ALG 1001
13 Unknown  Intravitreal Bone Marrow-Derived Stem Cells in Patients With Macular Degeneration
Condition: Age Related Macular Degeneration and Stargartd
Intervention: Other: intravitreal injection of autologous bone marrow stem cells
14 Recruiting Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases
Conditions: Macular Degeneration;   Stargardt's Macular Dystrophy
Intervention: Procedure: Subretinal transplantation
15 Unknown  A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: DE-120
16 Withdrawn Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: Telescope prosthesis;   Device: WA-NG Telescope Prothesis
17 Active, not recruiting A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: DE-120;   Drug: Aflibercept
18 Terminated
Has Results
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Regorafenib, ophthalmic oily suspension (BAY73-4506);   Procedure: Sham IVT;   Drug: Ranibizumab;   Drug: Placebo
19 Active, not recruiting Brain Connectivity in Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention:
20 Recruiting Study of DS-7080a for the Treatment of Neovascular Age-Related Macular Degeneration
Condition: Neovascular Age-Related Macular Degeneration
Interventions: Drug: DS-7080a;   Drug: Ranibizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.